NIKA PHARMACEUTICALS, INC Cash And Cash Equivalents At Carrying Value

Quick Answer

NIKA PHARMACEUTICALS, INC reported Cash And Cash Equivalents At Carrying Value of $1.9 thousand for the year ending 2025.

  • NIKA PHARMACEUTICALS, INC showed a decrease of -9.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from NIKA PHARMACEUTICALS, INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), NIKA PHARMACEUTICALS, INC's Cash And Cash Equivalents At Carrying Value has grown by 17.3%.
  • Historical annual values: Fiscal year 2025: $1.9 thousand | Fiscal year 2024: $2.1 thousand | Fiscal year 2023: $19.6 thousand | Fiscal year 2022: $864.00 | Fiscal year 2021: $399.00 | Fiscal year 2020: $1.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: